Free Shipping on purchases over €100

Verolax Niños Solución Rectal, 6 Enemas

Verolax Children's Rectal Solution, 6 Enemas

Rectal solution indicated for the local symptomatic relief of transient and occasional constipation in children aged 2-12 years.

Contains 6 enemas.

SKU: 854042
-5%
10.87
€11.44
Medicamento

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

What is Verolax Children and what is it used for?

It isa medicine for children for rectal use with a laxative action that is achieved by the stool softening capacity of glycerol, which, together with a slight local irritant action, stimulates bowel movements.

It comes in a pack containing 6 enemas.

Who it is intended for

Its use is indicated for the local symptomatic relief of transient and occasional constipation for children between 2 and 12 years of age .

Instructionsfor use

This medicine is administered rectally. The usual dose is 1 single-dose container per day.

Instructions for the correct administration of the medicine:

  1. Open the applicator, grasping it by the neck and twist the cap, making it easy to break the seal.

Interfaz de usuario gráfica, Aplicación

Descripción generada automáticamente con confianza media

  1. Squeeze lightly so that a few drops of the medicine moisten the end of the cannula, in order to facilitate its introduction into the rectum.

  1. Gently and slowly insert the cannula of the applicator into the rectum.

  1. Introduce the contents of the applicator by pressing on the walls of the bellows and gently withdraw it once the application has been completed.

If at the time of administrationyou feel resistance, you should discontinue the administration, as it may be harmful and damaging.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.